Detalhe da pesquisa
1.
Corrigendum to "Nitazoxanide superiority to placebo to treat moderate COVID-19 - A Pilot prove of concept randomized double-blind clinical trial." [EClinicalMedicine 37 (2021) 100981].
EClinicalMedicine
; 41: 101203, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34805808
2.
Nitazoxanide superiority to placebo to treat moderate COVID-19 - A Pilot prove of concept randomized double-blind clinical trial.
EClinicalMedicine
; 37: 100981, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-34222847